NCT05957471View on ClinicalTrials.gov

Study of BC3195 Monotherapy in Patients With Advanced Solid Tumors

PHASE1UnknownINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

June 26, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Locally Advanced or Metastatic Solid Tumors
Interventions
DRUG

Drug: BC3195 for Injection

BC3195 via intravenous(IV).

Trial Locations (1)

510060

RECRUITING

Guangdong Provincial People's Hospital, Guangzhou

Sponsors
All Listed Sponsors
lead

Biocity Biopharmaceutics Co., Ltd.

INDUSTRY